Filing Details
- Accession Number:
- 0001415889-24-008260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-18 16:06:28
- Reporting Period:
- 2024-03-14
- Accepted Time:
- 2024-03-18 16:06:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1810182 | Alx Oncology Holdings Inc | ALXO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1688269 | Jason Lettmann | C/O Alx Oncology Holdings Inc. 323 Allerton Avenue South San Francisco CA 94080 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-14 | 4,400 | $11.31 | 171,620 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
